Recalls & Warnings December 13, 2013 Maker of Menopause Blend and Other Supplement Ingredients Warned by FDA of Violations On November 21, 2013, the FDA issued a warning letter to Raw Deal, Inc
See our injury recovery guide for details
doi: 10.1016/j.clpt.2005.09.009
Such registries, coupled with independent product verification and transparent conflict-of-interest disclosure, represent a critical step toward determining whether clinically meaningful benefit exists and whether perioperative risk can be quantified
In this context, glutaminase 1 (GLS1), expressed in the mitochondria of several malignant tumors (ovarian cancer, breast tumor cells, colorectal cancer), promotes glutamine degradation to support cellular proliferation [200,201,202]
In Acetaminophen Toxicity 395415 (Elsevier, 2025)